Celldex Therapeutics, Inc. (CLDX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 28.35 |
| Open | 28.43 |
| Bid | 11.24 x 800 |
| Ask | 33.10 x 1200 |
| Day's range | 27.96 - 30.07 |
| 52-week range | 19.85 - 57.20 |
| Volume | |
| Avg. volume | 675,396 |
| Market cap | 1.312B |
| Beta (5Y monthly) | 2.49 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.02 |
| Earnings date | 07 Nov 2022 - 11 Nov 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 67.00 |
- Zacks
Celldex Therapeutics (CLDX) Reports Q2 Loss, Lags Revenue Estimates
Celldex (CLDX) delivered earnings and revenue surprises of -34.88% and 53.43%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Wall Street Analysts See a 169% Upside in Celldex (CLDX): Can the Stock Really Move This High?
The mean of analysts' price targets for Celldex (CLDX) points to a 169.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
- Zacks
Celldex (CLDX) Surges 9%: Is This an Indication of Further Gains?
Celldex (CLDX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
© 2022 Yahoo. All rights reserved.
